Sotagliflozin May Steal the Spotlight in Heart Failure, but Questions Remain

Although newly approved, there is some debate regarding the benefits and populations in which sotagliflozin will be the most effective.

Related Keywords

United States , ,Lexicon Pharmaceuticals Inc ,York Heart Association ,New York Heart Association ,American College ,American Heart Association ,Quick Facts ,Injury Incidence ,Global Burden ,Disease Study ,Heart Failure ,American Heart Association Joint Committee ,Clinical Practice ,Lexicon Pharmaceuticals ,Nat Cardiovasc Res ,Recent Worsening Heart ,Chronic Kidney ,